Curative Biotechnology
OTC: CUBTBoca Raton, US · Florida corporation
Founders & leadership
MF
Michael FishNamed on SEC filing
BG
Barry GinsbergNamed on SEC filing
GR
Garr RichardNamed on SEC filing
PM
Paul MichaelsNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.1M disclosed across 2 rounds · 2022
▶$146KraisedJan 2023 · 11 investors · PharmaceuticalsRule 506(b)
▶$146KraisedJan 2023 · 11 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michael FishDirector
- Lawrence ZaslowDirector
- Paul MichaelsExecutive Officer, Director
- Barry A. GinsbergExecutive Officer, Director
- I Richard GarrExecutive Officer
- Cary SucoffDirector
- Offering amount
- $919K
- Amount sold
- $146K
- Proceeds to insiders
- $146K
- First sale
- Dec 2022
- Incorporated
- Corporation, Florida
- Federal exemptions
- 06b
▶$1MraisedMar 2022 · 1 investors · PharmaceuticalsRule 506(b)
▶$1MraisedMar 2022 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michael FishDirector
- Barry GinsbergExecutive Officer, Director
- Garr RichardExecutive Officer
- Paul MichaelsExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $1M
- Minimum investment
- $1M
- Sales commissions
- $102.5K
- Placement agents
- Aegis Capital Corp.
- First sale
- Mar 2022
- Incorporated
- Corporation, Florida
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Curative Biotechnology raised?
- Curative Biotechnology has disclosed $1.1M raised across 2 rounds.
- Where is Curative Biotechnology headquartered?
- Curative Biotechnology is headquartered in Boca Raton, US.